Recommendations for useful serum testing with suspected multiple sclerosis

Revue Neurologique

Volumn 169, Issue 1, 2013, Pages 37-46

  Ouallet, J C ^a   Bodiguel, E ^b,c,d   Bensa, C ^e   Blanc, F ^f   Brassat, D ^g   Laplaud, D ^h   Zephir, H ⁱ   De Seze, J ^f   Magy, L ^j  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c CENTRE HOSPITALIER SAINTE ANNE   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

^f UNIVERSITÉ DE STRASBOURG   (France)

^g UNIVERSITÉ PAUL SABATIER   (France)

^h INSERM   (France)

ⁱ UNIV LILLE   (France)

^j LIMOGES UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Blood; Diagnosis; Multiple sclerosis; Practice guideline; RAND Ucla appropriateness method; Review

Indexed keywords

CD31 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE B; PADGEM PROTEIN; STAT1 PROTEIN; T LYMPHOCYTE ANTIBODY; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR T BET;

ANTIBODY DETECTION; ARTICLE; BLOOD CELL COUNT; BLOOD EXAMINATION; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; FRIEDREICH ATAXIA; HEREDITARY MOTOR SENSORY NEUROPATHY; IMMUNOCOMPETENT CELL; MICROARRAY ANALYSIS; MULTIPLE SCLEROSIS; MYELITIS; MYOTONIC DYSTROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; SEROLOGY; SPINOCEREBELLAR DEGENERATION;

ADULT; BIOLOGICAL MARKERS; CONSENSUS; DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; EVIDENCE-BASED MEDICINE; FRANCE; GUIDELINES AS TOPIC; HEMATOLOGIC TESTS; HOSPITALIZATION; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; MYELITIS; REPRODUCIBILITY OF RESULTS;

EID: 84873414652     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2011.09.007     Document Type: Article

References (24)

1. Agence Nationale d'Accréditation et d'Évaluation en Santé (ANAES). Guide d'analyse de la littérature et gradation des recommandations. Janvier 2000.
2. T. Berger, P. Rubner, F. Schautzer, R. Egg, H. Ulmer, and I. Mayringer Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event N Engl J Med 349 2003 139 145
3. J. de Seze, C. Lanctin, C. Lebrun, I. Malikova, C. Papeix, and S. Wiertlewski Idiopathic acute transverse myelitis: application of the recent diagnostic criteria Neurology 65 2005 1950 1953
4. E. Fainardi, M. Castellazzi, T. Bellini, M.C. Manfrinato, E. Baldi, and I. Casetta Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis Mult Scler 12 2006 294 301
5. Fédération Française de Neurologie (FFN), and Agence Nationale d'Accréditation et d'Evaluation en Santé française (ANAES) La sclérose en plaques. Conférence de consensus Rev Neurol (Paris) 157 2001 904 1192
6. K. Fitch, S.J. Bernstein, M.D. Aguilar, B. Burnand, J.R. LaCalle, and P. Lazaro The RAND/UCLA appropriateness method user's manual 2001 RAND Santa Monica (CA)
7. G. Frisullo, F. Angelucci, M. Caggiula, V. Nociti, R. Iorio, and A.K. Patanella pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity J Neurosci Res 84 2006 1027 1036
8. J.M. Greer, and M.P. Pender Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis J Autoimmun 31 2008 281 287
9. J.M. Greer, P.A. Csurhes, D.M. Muller, and M.P. Pender Correlation of blood T cell and antibody reactivity to myelin proteins with HLA type and lesion localization in multiple sclerosis J Immunol 180 2008 6402 6410
10. V.K. Harris, and S.A. Sadiq Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making Mol Diagn Ther 13 2009 225 244
11. Haute Autorité de Santé: bases méthodologiques pour l'élaboration de recommandations professionnelles par consensus formalisé (janvier 2006). www.has-sante.fr.
12. Haute Autorité de Santé: guide affection longue durée : sclérose en plaques (septembre 2006). www.has-sante.fr.
13. Haute Autorité de Santé: méthode et processus d'adaptation des recommandations pour la pratique clinique existantes (février 2007). www.has-sante.fr.
14. C. Infante-Duarte, A. Weber, J. Krätzschmar, T. Prozorovski, S. Pikol, and I. Hamann Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patients FASEB J 19 2005 1902 1904
15. A. Jacob, and B.G. Weinshenker An approach to the diagnosis of acute transverse myelitis Semin Neurol 28 2008 105 120
16. B. Kuenz, A. Lutterotti, M. Khalil, R. Ehling, C. Gneiss, and F. Deisenhammer Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis J Neuroimmunol 167 2005 143 149
17. D.A. Laplaud, L. Berthelot, P. Miqueu, K. Bourcier, J. Moynard, and Y. Oudinet Serial blood T cell repertoire alterations in multiple sclerosis patients; correlation with clinical and MRI parameters J Neuroimmunol 177 2006 151 160
18. W.I. McDonald, A. Compston, G. Edan, D. Goodkin, H.P. Hartung, and F.D. Lublin Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis Ann Neurol 50 2001 121 127
19. D.D. Mikol, C. Ditlow, D. Usatin, P. Biswas, J. Kalbfleisch, and A. Milner Serum IgE reactive against small myelin protein-derived peptides is increased in multiple sclerosis patients J Neuroimmunol 180 2006 40 49
20. D.H. Miller, B.G. Weinshenker, M. Filippi, B.L. Banwell, J.A. Cohen, and M.S. Freedman Differential diagnosis of suspected multiple sclerosis: a consensus approach Mult Scler 14 2008 1157 1174
21. C.H. Polman, S.C. Reingold, G. Edan, M. Filippi, H.P. Hartung, and L. Kappos Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria" Ann Neurol 58 2005 840 846
22. C. Ramirez, J. de Seze, S. Delalande, E. Michelin, D. Ferriby, and A. Al Khedr Myélopathies infectieuses: profils cliniques, paracliniques et évolutifs Rev Neurol (Paris) 160 2004 1048 1058
23. M. Schwarz, L. Spector, M. Gortler, O. Weisshaus, L. Glass-Marmor, and A. Karni Serum anti-Glc(alpha1,4) Glc(alpha) antibodies as a biomarker for relapsing-remitting multiple sclerosis J Neurol Sci 244 2006 59 68
24. Transverse Myelitis Consortium Working Group Proposed diagnostic criteria and nosology of acute transverse myelitis Neurology 59 2002 499 505